Source: Investing.com ↗

Stifel reiterates Buy on NewAmsterdam Pharma stock after trial failure

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$86,249.99

+0.92%

ETH/USDT

$2,746.70

+0.54%

ZEC/USDT

$1,622.62

+7.29%

XRP/USDT

$1.61

+5.92%